WST Stock-Based Compensation
West Pharmaceutical Services · Stock-Based Compensation

WST Stock-Based Compensation
Latest reported$32.60Mperiod ending
WST Stock-Based Comp ($0.00 → $32.60M)
Annual stock-based compensation
High-resolution chart · PNG
WST stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 23,800,000 | |
| 18,700,000 | |
| 23,300,000 | |
| 23,700,000 | |
| 37,500,000 | |
| 34,000,000 | |
| 24,400,000 | |
| 15,100,000 | |
| 16,100,000 | |
| 19,500,000 | |
| 29,600,000 | |
| 18,600,000 | |
| 21,200,000 | |
| 15,500,000 | |
| 8,400,000 | |
| 7,800,000 | |
| 7,500,000 | |
| 6,400,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |